DBV Technologies S.A.
DBV Technologies S.A., a pioneering biopharmaceutical company headquartered in France, focuses on developing innovative treatments for food allergies and other immune-mediated diseases. Founded in 2002, the company has made significant strides in the field of immunotherapy, particularly with its proprietary Viaskin® technology, which offers a unique, non-invasive method for delivering therapeutic proteins through the skin. With a strong presence in Europe and North America, DBV Technologies is recognised for its commitment to advancing patient care through its core product offerings, including the Viaskin Peanut patch, designed to desensitise individuals with peanut allergies. The company has achieved notable milestones, including successful clinical trials and partnerships that enhance its market position in the biopharmaceutical industry. As a leader in allergy treatment innovation, DBV Technologies continues to shape the future of immunotherapy.
DitchCarbon Score
How does DBV Technologies S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
DBV Technologies S.A.'s score of 21 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
DBV Technologies S.A.'s reported carbon emissions
DBV Technologies S.A., headquartered in France, currently does not have publicly available carbon emissions data or specific reduction targets. As a result, there are no reported figures for their Scope 1, 2, or 3 emissions. The company has not outlined any formal climate commitments or initiatives aimed at reducing carbon emissions. In the absence of specific data, it is unclear how DBV Technologies is addressing climate change or contributing to sustainability efforts within the biotechnology sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
DBV Technologies S.A. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
